Connection

Valerie Durkalski-Mauldin to Treatment Outcome

This is a "connection" page, showing publications Valerie Durkalski-Mauldin has written about Treatment Outcome.
Connection Strength

0.174
  1. Time-trend impact on treatment estimation in two-arm clinical trials with a binary outcome and Bayesian response adaptive randomization. J Biopharm Stat. 2020; 30(1):69-88.
    View in: PubMed
    Score: 0.071
  2. Convalescent Plasma for Outpatients with Covid-19. Reply. N Engl J Med. 2021 12 02; 385(23):2206-2207.
    View in: PubMed
    Score: 0.021
  3. Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2. Stroke. 2020 08; 51(8):2282-2286.
    View in: PubMed
    Score: 0.019
  4. Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial. JAMA. 2019 07 23; 322(4):326-335.
    View in: PubMed
    Score: 0.018
  5. Assessing the Burden of Abnormal LFTs and the Role of the Electronic Health Record: A Retrospective Study. Am J Med Sci. 2018 Jun; 355(6):537-543.
    View in: PubMed
    Score: 0.016
  6. Duloxetine for the Treatment of Patients with Suspected Sphincter of Oddi Dysfunction: A Pilot Study. Dig Dis Sci. 2016 09; 61(9):2704-9.
    View in: PubMed
    Score: 0.015
  7. Intramuscular midazolam versus intravenous lorazepam for the prehospital treatment of status epilepticus in the pediatric population. Epilepsia. 2015 Feb; 56(2):254-62.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.